Foster Corporation Achieves 2024 EcoVadis Silver Status, Recognized for Exceptional Sustainability Efforts

PUTNAM, CT USA – (11-18-24) – Foster Corporation, a leading provider of polymer material solutions for the medical device industry, has been awarded EcoVadis Silver status for 2024. This recognition is a testament to the company’s longstanding dedication to sustainability and environmental responsibility. Achieving EcoVadis Silver status places Foster Corporation among the top 15% of all companies in the rubber and plastics industry in their size category for environmental and sustainability initiatives.

EcoVadis, a globally recognized platform, assesses businesses’ sustainability performance across four key categories: environmental impact, labor and human rights, ethics, and sustainable procurement practices. Since its establishment in 2007, EcoVadis has set a high standard for business sustainability assessments, becoming a trusted benchmark for organizations worldwide.

“This EcoVadis Silver certification is a major milestone for Foster,” said Larry Acquarulo, CEO and owner of Foster Corporation. “While we have earned bronze and silver certifications in the past, EcoVadis continuously raises the bar for sustainability performance, making it increasingly challenging to achieve high ratings. Our team did an outstanding job identifying what needed to be done, creating a strategic plan, and executing it to perfection.”

Mr. Acquarulo added, “Our commitment to sustainability is stronger than ever. The EcoVadis framework pushes organizations to keep improving, and Foster is dedicated to meeting that challenge head-on to protect the environment and advance our sustainability goals.”

Foster Corporation remains dedicated to driving substantial environmental and sustainability efforts and looks forward to continued progress in this critical area.

###

About Foster Corporation
For over thirty-five years, Foster Corporation has been serving medical device and pharmaceutical manufacturers with industry-leading technology and service in biomedical materials. These include custom medical compounds, implantable materials, drug/polymer blends, and polymer distribution. Within ISO 13485:2016/ISO 14001:2015 facilities, Foster offers comprehensive support to customers from formulation development through production.  https://www.fostercomp.com